CBIO

Crescent Biopharma, Inc. Common Stock
CBIO

Overview Fund Activity

28 hedge funds and large institutions have $100M invested in Crescent Biopharma, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
28
Holders Change
+1
Holders Change %
+3.7%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
8
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$724K
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$658K
3
Deutsche Bank
3
Deutsche Bank
Germany
$363K
4
SIM
4
Spark Investment Management
New York
$453K
5
Blackstone Inc
5
Blackstone Inc
New York
$119K

Top Sellers

1
Franklin Resources
1
Franklin Resources
California
$6.42M
2
ARTA
2
A.R.T. Advisors
New York
$0
3
BPC
3
Banque Pictet & Cie
Switzerland
$0
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$18.7M
5
Goldman Sachs
5
Goldman Sachs
New York
$649K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$1K -$1K -1 -50%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$1K – – –
TCOV
28
Trust Company of Vermont
Vermont
$1K – – –
ARTA
29
A.R.T. Advisors
New York
– -$97K -141 Closed
BPC
30
Banque Pictet & Cie
Switzerland
– -$88K -126 Closed
TRCT
31
Tower Research Capital (TRC)
New York
– -$1K -2 Closed
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
– -$1.3K -2 Closed
1
2